Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib/IIa Study of Cabazitaxel Plus Bavituximab for Patients With Castration-resistant Prostate Cancer Previously Treated With Chemotherapy

NCT01335204 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT01335204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01335204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib/IIa Study of Cabazitaxel Plus Bavituximab for Patients With Castration-resistant Prostate Cancer Previously Treated With Chemotherapy
Lead sponsor
Medical University of South Carolina
Phase
Phase 1/2
Overall status
Terminated
Start date
June 30, 2011
Completion date
March 31, 2013
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, prostatic neoplasms